Predicted protein targets (top 17)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TSHR | P16473 | 3/20 | 0.61 |
| ▸ | THRB | P10828 | 1/20 | 0.42 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.40 |
| ▸ | USP2 | O75604 | 1/20 | 0.33 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.33 |
| ▸ | MAPT | P10636 | 1/20 | 0.33 |
| ▸ | HPGD | P15428 | 1/20 | 0.33 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.33 |
| ▸ | POLB | P06746 | 1/20 | 0.32 |
| ▸ | APEX1 | P27695 | 1/20 | 0.32 |
| ▸ | HTT | P42858 | 1/20 | 0.32 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.32 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.30 |
| ▸ | DUSP3 | P51452 | 1/20 | 0.30 |
| ▸ | MEN1 | O00255 | 1/20 | 0.30 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.30 |
| ▸ | LMNA | P02545 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL27486615 | 1.00 | TSHR (0.61) | TSHRTHRBALDH1A1USP2CYP3A4 | |
| SCHEMBL94906 | 0.89 | TSHR (0.68) | TSHRTHRBALDH1A1USP2CYP3A4 | |
| SCHEMBL19998240 | 0.87 | TSHR (0.65) | TSHRTHRBALDH1A1USP2CYP3A4 | |
| SCHEMBL9972368 | 0.86 | TSHR (0.59) | TSHRTHRBALDH1A1USP2CYP3A4 | |
| SCHEMBL25707 | 0.83 | TSHR (0.61) | TSHRTHRBALDH1A1USP2CYP3A4 | |
| SCHEMBL137371 | 0.83 | TSHR (0.61) | TSHRTHRBALDH1A1USP2CYP3A4 | |
| SCHEMBL3412123 | 0.83 | TSHR (0.61) | TSHRTHRBALDH1A1USP2CYP3A4 | |
| SCHEMBL29375450 | 0.83 | TSHR (0.61) | TSHRTHRBALDH1A1USP2CYP3A4 | |
| SCHEMBL347487 | 0.83 | TSHR (0.61) | TSHRTHRBALDH1A1USP2CYP3A4 | |
| SCHEMBL16863053 | 0.83 | TSHR (0.61) | TSHRTHRBALDH1A1USP2CYP3A4 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 90 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-3861039-B1 | HYDROGEL COMPOSITIONS | OPHTALMIC CIE (FR) | 2023-11-01 | — | — | EP | claimed |
| CN-115379826-B | Boundary surface charged contact lens for delivery | 领视药公司 | 2023-07-21 | — | — | CN | claimed |
| US-20230190644-A1 | POROUS NANOCOMPOSITE MEDICAL IMPLANT DEVICE | LYNTHERA CORPORATION | 2023-06-22 | — | — | US | claimed |
| CN-115215963-B | Blue light resistant cornea contact lens and preparation method thereof | 江苏海伦隐形眼镜有限公司 | 2023-06-13 | — | — | CN | claimed |
| EP-4188331-A1 | BOUNDARY SURFACE CHARGED CONTACT LENS FOR DELIVERY | Lynthera Corporation (US) | 2023-06-07 | — | — | EP | claimed |
| EP-4135728-A1 | POROUS NANOCOMPOSITE MEDICAL IMPLANT DEVICE | Lynthera Corporation (US) | 2023-02-22 | — | — | EP | claimed |
| CN-115666598-A | Porous nanocomposite medical implant device | 领视药公司 | 2023-01-31 | — | — | CN | claimed |
| CN-112159505-B | Medium-water-content and high-oxygen-permeability silicone hydrogel and silicone hydrogel contact lens | 甘肃天后光学科技有限公司 | 2022-12-20 | — | — | CN | claimed |
| US-11504323-B2 | Boundary surface charged contact lens for delivery | LYNTHERA CORPORATION (US) | 2022-11-22 | — | — | US | claimed |
| CN-115379826-A | Charged contact lenses with boundary surfaces for delivery | 领视药公司 | 2022-11-22 | — | — | CN | claimed |
| US-10617559-B2 | High-precision drug delivery by dual-domain ocular device | LYNTHERA CORPORATION (US) | 2020-04-14 | — | — | US | claimed |
| WO-2020070423-A1 | HYDROGEL COMPOSITIONS | OPHTALMIC COMPAGNIE (FR) | 2020-04-09 | — | — | WO | claimed |
| EP-3518844-A1 | HIGH-PRECISION DRUG DELIVERY BY DUAL-DOMAIN OCULAR DEVICE | Lynthera Corporation (US) | 2019-08-07 | — | — | EP | claimed |
| US-20190224045-A1 | HIGH-PRECISION DRUG DELIVERY BY DUAL-DOMAIN OCULAR DEVICE | LYNTHERA CORPORATION | 2019-07-25 | — | — | US | claimed |
| WO-2018064578-A1 | HIGH-PRECISION DRUG DELIVERY BY DUAL-DOMAIN OCULAR DEVICE | LYNTHERA CORPORATION (US) | 2018-04-05 | — | — | WO | claimed |
| CN-1675252-A | Macromer forming catalysts | JOHNSON & JOHNSON VISION CARE (US) | 2005-09-28 | — | — | CN | claimed |
| EP-0845708-B1 | PLATE FOR WATERLESS LITHOGRAPHY | TORAY INDUSTRIES (JP) | 2003-02-12 | — | — | EP | claimed |
| US-6106997-A | PRINTING DURABILITY, IMAGE REPRODUCIBILITY AND STORAGE STABILITY | TORAY INDUSTRIES, INC. (JP) | 2000-08-22 | — | — | US | claimed |
| EP-0845708-A1 | PLATE FOR WATERLESS LITHOGRAPHY | TORAY INDUSTRIES, INC. (JP) | 1998-06-03 | — | — | EP | claimed |
| WO-1997001114-A1 | CONTACT AND INTRAOCULAR LENSES CONTAINING ULTRAVIOLET ABSORBERS AND METHOD OF THEIR PRODUCTION | ÚSTAV MAKROMOLEKULÁRNÍ CHEMIE AKADEMIE VED C^¿ESKÉ REPUBLIKY (CZ) | 1997-01-09 | — | — | WO | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-11504323-B2 | Boundary surface charged contact lens for delivery | CRYZ, CLCN2, CRYAA | TSHR 3947/4885THRB 4392/4885ALDH1A1 4698/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.